GenerationsE Software Solutions, Inc.
AI-powered medical imaging solutions for early disease detection and accurate pathology evaluations.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| N/A | €0.0 Valuation: €0.0 | round | |
| investor | €0.0 | round | |
CAD500k | Angel | ||
| Total Funding | 000k | ||
| USD | 2022 | 2023 |
|---|---|---|
| Revenues | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
GenerationsE is a technology-driven company specializing in AI-powered medical imaging solutions aimed at revolutionizing healthcare. The company focuses on early detection of diseases such as Parkinson's and various gastrointestinal conditions through advanced image analysis of MRI, CT, and PET scans. GenerationsE collaborates with top medical research institutes, universities, hospitals, and medical device manufacturers to ensure reliable data sources and cutting-edge research. The business model revolves around providing AI-driven tools that assist pathologists in evaluating cancer cells promptly and accurately, thereby improving diagnostic efficiency and patient outcomes. Revenue is generated through partnerships, licensing of their proprietary technology, and service agreements with healthcare providers.
Keywords: AI, medical imaging, early detection, pathology, MRI, CT, PET, Parkinson's, gastrointestinal, healthcare.